💡 Did you know?
The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
History
The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
Arvee Laboratories (India) Limited is an India-based company engaged in manufacturing of specialized chemicals. The Company's product categories include polymer modifiers, contrast media intermediates and drug intermediates. Its polymer modifiers products include Dimethyl…
Weekly engine runs — movement reflects the numbers, not analyst opinion.
A decent, stagnant business, fully valued.
ARVEE LABORATORIES I LTD is scored on the general / industrial framework. It keeps a slim 7.9% of every rupee of sales as net profit. Cash conversion lags the reported profit (CFO/PAT -0.05×) — worth a closer look. Free cash flow is worth about 0.1% of its market value.
Over the last 3 years revenue compounded at -20%/yr and profit at -15%/yr. Book value has grown 6%/yr. Return on equity is a healthy 17.3%. In the latest quarter profit grew 225% versus the prior quarter.
At 99× earnings, the stock sits at the 70th percentile of its own 3.6-year range — the middle of where it has historically traded. Today's price implies ~18%/yr earnings growth for a decade. The books come through clean — a forensic grade of A, and Altman puts distress risk in the safe zone.
A plain-English restatement of the figures on this page — rules-based, for education and research context, not investment advice or a recommendation.
| Ratio | Company | Sector | Read |
|---|---|---|---|
| P/E | 37.97 | — | — |
| P/B | 6.59 | 2.66 | worse |
| EV/EBITDA | 23.97 | 9.95 | worse |
| ROE | 17.34 | — | — |
| ROCE | 20.25 | 70.06 | worse |
| ROA | 10.79 | 54 | worse |
| Quick Ratio | 2.23 | 2.26 | worse |
| Peer | P/E | P/B | ROE |
|---|---|---|---|
| Pidilite Industries | 59.1 | 14.3 | 23.9% |
| SRF | 32.3 | 4.8 | 14.9% |
| Linde India | 118.3 | 13.3 | 11.3% |
Revenue declined 18% in the latest year — a break from prior trajectory. Negative CAGR — the top line has shrunk over this window. Growth is decelerating — latest year grew slower than the year before.
Profit is growing faster than revenue (-15% vs -20%) — margin expansion is at work.
Operating margin has compressed from 10% to 8% — costs or competition are eating into profitability. Interest or tax burden is shrinking — more of the operating profit is reaching the bottom line.
ROE at 7% — modest; the capital isn't working hard. Capital efficiency declining — ROE down 7pp.
-15% EPS CAGR — this is the rate at which each share's claim on earnings is compounding.
2 of 4 years had negative operating cash flow — profitability on paper may not translate to cash. Financing outflows in consecutive years — balance-sheet discipline through debt repayment or dividends.
When operating cash keeps pace with reported profit, earnings are cash-backed; a persistent shortfall is a quality flag.
Revenue rose 59% sequentially — momentum is building. Wide quarterly swings (79% spread) — likely seasonality, lumpy orders, or project-based revenue. Run-rate stepping up — recent quarters average 109% above earlier ones.
Profit jumped 225% QoQ — check if this is operating leverage or a one-off item. Quarterly net margins are expanding (0% → 10%) — profitability per rupee of revenue is improving.
How today's P/E compares to the stock's own historical range. Dashed line = the 3.6y median.
Promoters hold 73.5% — heavily owner-operated with strong skin in the game.
Produced by a rules-based engine over licensed exchange fundamentals — every sentence above is derived from the numbers shown, no analyst or AI opinion involved. Education and research context, not investment advice. We are not SEBI-registered as an Investment Adviser or Research Analyst.